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6-substituted benzimidazoles Nonpeptide Angiotensin II Receptor Antagonists by using k-Nearest
Neighbor Molecular Field Analysis (kNN-MFA) combined with various selection procedures.
Molecular ﬁeld analysis was applied for the generation master grid maps derived from the best
model has been used to display the contribution of electrostatic potential and steric, hydrophobic
ﬁeld based on aligned structures. Partial least square methodology coupled with various feature
selection methods, viz. stepwise (SW), genetic algorithm (GA) and simulated annealing (SA) were
applied to derive QSAR models which were further validated for statistical signiﬁcance and predic-
tive ability by internal and external validation. By using kNN-MFA approach, various 3D QSAR
models were generated to study the effect of steric, electrostatic and hydrophobic descriptors on
Ang II activity. The best model B with good external and internal predictivity for the training
and test set has shown cross-validation (q2) and external validation (pred_r2) values of 0.8269
and 0.7647, respectively. For this model training and test sets were selected using sphere exclusion
method and the descriptors were selected using simulated annealing method. The summary of the26372944.
oo.com (M.C. Sharma).
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Saud University.
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D license.
168 M.C. Sharma et al.selected model can be given as: k= 4, r2 = 0.8753, F test = 74.643, r2_se = 0.2143,
q2_se = 0.4365, pred_r2se = 0.2165 and descriptors at the grid points S_1018, E_563, S_2083,
E_1460, E_160, H_2234, H_2491 and H_1146 play an important role in the design of new molecule.
Contour maps using this approach showed that steric, electrostatic and hydrophobic effects
dominantly determine binding afﬁnities. The information rendered by 3D QSAR models may lead
to a better understanding of structural requirements of antihypertensive activity and can help in the
design of novel potent molecules.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.
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The renin–angiotensin system (RAS) is well established as an
endocrine system involved in blood pressure (BP) and ﬂuid
electrolyte balance. Renin, an aspartyl protease, cleaves
angiotensinogen to produce angiotensin I, which is further
converted by angiotensin converting enzyme (ACE) to the
potent vasoconstrictor, angiotensin II. Since angiotensinogen
is the only substrate known for renin and cleavage of angioten-
sinogen by renin is the rate determining step in the RAS, it is of
general consensus that inhibition of renin would be the optimal
strategy for the control of hypertension (Stanton, 2003;
Rosenberg and Boyd, 1997). Renin, a proteolytic enzyme pro-
duced mainly in the juxtaglomerular apparatus of the kidney,
acts on the circulating alpha globulin angiotensinogen pro-
duced by the liver to form the decapeptide Asp-Arg-Val-Tyr-
Ileu-His-Pro-Phe-His-Leu, named angiotensin I. Angiotensin
I is relatively inert but is converted to the active octapeptide
Asp-Arg-Val-Tyr-Ileu-His-Pro-Phe, named as angiotensin II
by angiotensin-converting enzyme (ACE) present in lungs
and other organs. Among them, angiotensin-converting en-
zyme (ACE) inhibitors have been very successful in the treat-
ment of hypertension and congestive heart failure during the
last few decades. However, these inhibitors suffer from some
side effects such as dry cough and angioedema caused by their
nonspeciﬁc actions (Chin and Buchan, 1990; Wood et al.,
1990). On the other hand, angiotensin II (Ang II) receptor
antagonists block the RAS at the Ang II receptor level. This
provides a more speciﬁc attempt to inhibit the activity of the
RAS and has become the main pharmacological approach
(Cockcroft et al., 1993). The therapeutic proﬁle of Ang II
receptor antagonist is thought to be similar to that of angioten-
sin converting enzyme (ACE) inhibitors such as captopril,
enalapril and lisinopril. In addition, since Ang II receptor
antagonist does not affect the metabolism of bradykinin so
they may not have the side effect of ACE inhibitors, such as
dry cough and angiodema. Computational chemistry predic-
tion of biological activity based quantitative structure–activity
relationship (QSAR) substantially increases the potential of
work, avoiding time and resource consuming experiments
(Dlazand Prado, 2008). The most popular 3D-QSAR methods
are comparative molecular ﬁeld analysis CoMFA (Cramer
et al., 1988) and comparative molecular similarity analysis
CoMSIA (Klebe et al., 1994). The CoMFA method involves
generation of a common three-dimensional lattice around a
set of molecules and calculation of the steric and electrostatic
interaction energies at the lattice points while the CoMSIA
method uses the similarity functions represented by Gaussian
(Kubinyi, 1993). Numerous data sets reported in the literature
were subjected to QSAR analysis for the purpose of designing
novel angiotensin II receptor antagonists (Belvisi et al., 1996;Datar et al., 2004; Kurup et al., 2001; Sharma et al., 2009).
Newly reported method k-Nearest Neighbor Molecular Field
Analysis (kNN-MFA) adopts a k-Nearest Neighbor principle
for generating relationship of molecular ﬁelds with the experi-
mentally reported activity. This method utilizes the active ana-
logue principle that lies at the foundation of medicinal
chemistry. For the development of 3D-QSAR, molecular ﬁeld
analysis (Ajmani et al., 2006) has been applied to evaluate spe-
ciﬁc contributions of steric and electrostatic ﬁeld effects neces-
sary for the activity variation of 6-substituted benzimidazole
derivatives. These steric, electrostatic and hydrophobic ﬁeld
descriptors are useful for the better understanding of molecu-
lar modeling studies. In the present investigation, three widely
used techniques; viz. stepwise (SW) forward variable selection
method, genetic algorithm (GA) and simulated annealing (SA)
have been applied for descriptor optimization. In the present
study, an attempt has been made to formulate 3D-QSAR mod-
els using partial least-squares (Hoskuldsson, 1995) methodol-
ogy. It is expected that such 3D-QSAR molecular modeling
studies of 6-substituted benzimidazoles angiotensin II antago-
nist will provide better tools for rational design of promising
antihypertensive activity having greater therapeutic safety
and efﬁcacy. Our aim is to utilize these activity data for the
development of a valid 3D-QSAR model based on steric, elec-
trostatic and hydrophobic ﬁelds that gives a deep insight into
structure property activity correlations.
2. Materials and methods
2.1. Biological activity data
A number of 40 compounds 6-substituted benzimidazoles
derivatives having angiotensin II antagonist activities were
considered in the present study. The angiotensin II antagonist
activity data of synthesized 6-substituted benzimidazole deriv-
atives were taken from the reported work (Uwe et al., 1993).
Biological activity expressed in terms of IC50 was converted
in to pIC50 (pIC50 = log 1/IC50). Table 1 shows the structure
of 40 such compounds along with their biological activity val-
ues. 6-substituted benzimidazoles led the systematic variation
of several substituents at the benzimidazole ring positions
4–7. Out of these 40 compounds, small aliphatic substituents
such as –CH3, –NH2, –NHCOCH3, and NHCONCH3, are at-
tached at 4–7-positions of compounds. The total set of inhib-
itors was divided into a training set (28 compounds) for
generating 3D QSAR models and a test set (12 compounds)
for validating the quality of the models. The training set and
test set were selected manually by considering the fact that
the test-set compounds represent structural diversity and a
range of biological activities similar to that of the training
set. In addition, the wide range of structural diversity of
Table 1 Biological activity data and structures of the 6-substituted benzimidazoles derivatives.
Compounds- 1-17
N
N
Bu
XH
Compounds- 18-30
R
N
N
n-Pr
XH
Compounds- 31-40
R2
R1
N
N
Bu
COOH
R
Comp. R R1 R2 XH IC50
a (nM) pIC50
b
1 H – – – 400 6.39
2 4-CH3 – – – 1200 5.92
3 5-CH3 – – – 1200 5.92
4c 6-CH3 – – – 850 6.07
5 7-CH3 – – – 480 6.31
6 4-NH2 – – – 1700 5.76
7 5-NH2 – – – 820 6.08
8c 6-NH2 – – – 540 6.26
9 7-NH2 – – – 1060 5.97
10 4-NHCOCH3 – – – 5700 5.24
11 5-NHCOCH3 – – – 460 6.33
12c 6-NHCOCH3 – – – 180 6.74
13 7-NHCOCH3 – – – 1800 5.74
14 4-NHCONHC6H11 – – – 29,300 4.53
15 5-NHCONHC6H11 – – – 800 6.09
16c 6-NHCONHC6H11 – – – 26 7.58
17 7-NHCONHC6H11 – – 160 6.79
18 –CH3(CH2)4NH – – COOH 390 6.40
19c
N
– – COOH 160 6.79
20 –CH3(CH2)3–CONH – – COOH 86 7.06
21 –(CH3)2NCONH – – COOH 24 7.61
22 –C6H11NHCONCH3 – – COOH 26 7.58
23c –CH3(CH2)2SO2NCH3 – – COOH 33 7.48
24
N
S
OO
– – COOH 34 7.46
25
N
O – – COOH 81 7.09
26 –C6H11NHCONH – – Tetrazole 21 7.67
27 –C6H11NHCONCH3 – – Tetrazole 10 8
28c –(CH3)2NCONH – – Tetrazole 8 8.09
29
N
S
OO
– – Tetrazole 3 8.52
30c
N
O – – Tetrazole 4 8.39
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Table 1 continued
Comp. R R1 R2 XH IC50
a (nM) pIC50
b
31 – CH3
N
N
CH3
COOH 3 8.52
32c – H
N
N
CH3
COOH 3 8.52
33 – CH3
N
N
CH3
Tetrazole 13 7.88
34c – H
N
N
CH3
Tetrazole 5 8.30
35 – CH3
N
N COOH 4 8.39
36c – CH3
N
N Tetrazole 3 8.52
37 – CH3
N
Tetrazole 5 8.30
38c – H
N
Tetrazole 11 7.95
39 – H
N
O
N Tetrazole 240 6.61
40 – CH3 (CH3)2NCH2 COOH 158 6.80
a IC50 for speciﬁc binding of [
125I] AII to rat lung membrane preparation.
b Logarithmic value of IC50.
c Compounds belonging to test set.
170 M.C. Sharma et al.compounds in the test set permitted us to evaluate the extrap-
olative accuracy of the QSAR models.
2.2. Geometry optimization
The models developed using the training set was used to predict
the activity of the compounds in the test set. All the molecular
modeling studies (3D) were performed using Molecular Design
Suite supplied by the VLife Sciences, Pune (www.vlifesciences.
com) on Compaq PC having Pentium IV processor and win-
dows XP operating system. The structures were sketched using
the 2D draw application and converted to 3D structures.Three-dimensional structures were drawn for each molecule
and the molecular geometries optimized using Monte Carlo
conformational search (Metropolis et al., 1953), which uses
the metropolis condition to accept or discard generated con-
formers and energy minimization and geometry optimization
were conducted using theMerck molecular force ﬁeld (MMFF)
(Gasteiger and Marsili, 1980) method with the root mean
square (RMS) gradient set to 0.01 kcal/mol A, and the iteration
limit to 10,000. Optimal training and test set were generated
using the sphere exclusion algorithm. The sphere exclusion
(SE) method (Golbraikh and Tropsha, 2002) was adopted for
division of training and test data set comprising of 28 and 12
Figure 1 Template based alignment of benzimidazole
derivatives.
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the dissimilarity value gives the sphere exclusion radius. In clas-
sical sphere-exclusion algorithm the molecules are selected
whose similarities with each of the other selected molecules
are not higher than a deﬁned threshold. Each selected molecule
generates a hyper-sphere around itself, so that any molecule in-
side the sphere is excluded from the selection in the train set
and driven toward the test set. The number of compounds se-
lected and the diversity among them can be determined by
adjusting the radius of the sphere (R). Twelve compounds,
namely, 4, 8, 12, 16, 19, 23, 28, 30, 32, 34, 36 and 38 were used
as test set while the remaining molecules as the training set. The
standard leave-one-out (LOO) procedure was implemented to
calculate cross-validated r2 (q2) value, that is a molecule in
the training set was eliminated and its biological activity was
predicted as the weighted average activity of the k most similar
molecules. The unicolumn statistical analysis can be (Table 3)
interpreted to mean that the maximum of the test is less than
the maximum of the training set and the minimum of the test
is greater than the minimum of the training set to have maxi-
mum and minimum activity in the training set to obtain struc-
ture diversity. It also shows that in all these cases the test set
was interpolative, i.e., derived within the minimum–maximum
range of the training set. The mean and standard deviation of
the training and test sets provided an insight to the relative dif-
ference of mean and point density distribution (along mean) of
the two sets. The mean of the test sets was higher than the train-
ing sets which indicates the presence of relatively more active
molecules as compared to the inactive ones. Also, in both the
cases a relatively higher standard deviation in training sets indi-
cates that training sets had widely distributed activity of the
molecules as compared to the test sets.
2.3. Alignment of molecules
Molecular alignment is a crucial step in 3D-QSAR study to ob-
tain meaningful results. This method is based on moving of
molecules in 3D space, which is related to the conformational
ﬂexibility of molecules. Energy minimized and geometry opti-
mized structure of molecules were aligned by the template-
based method (Ajmani et al., 2006) where a template structure
is deﬁned and used as a basis for alignment of a set of mole-
cules, and a reference molecule is chosen on which the othermolecules of the dataset get aligned considering the chosen tem-
plate. The template structure, i.e., benzimidazole ring was used
for alignment by considering the common elements of the series
as shown in Fig. 1. The reference molecule is chosen in such a
way that it is the most active among the series of molecules
considered. The goal is to obtain optimal alignment between
the molecular structures necessary for alignment compounds
(Cramer et al., 1988). Alignment of all 40 compounds was done
using the template-based alignment in MDS; the aligned struc-
tures were used for the study. These aligned conformations
were used to generate the predictive QSAR model.
2.4. Methodology
For calculation of ﬁeld descriptor values, using Tripos force
ﬁeld (Clark et al., 1989) steric, electrostatic and hydrophobic
ﬁeld types with cut-offs of 10.0 and 30.0 kcal/mol, respectively,
were selected and charge type was selected as by Gasteiger and
Marsili (1980). Steric, electrostatic and hydrophobic ﬁelds
are computed at each grid point considering MMFF charges
(Halgren, 1996). Methyl probe of charge +1 with 10.0 kcal/
mol electrostatic and 30.0 kcal/mol steric, hydrophobic cut-
off were used for ﬁelds generation. A value of 1.0 is assigned
to the distance-dependent dielectric constant. This resulted in
calculation of 8124 ﬁeld descriptors (2708 for each steric, elec-
trostatic and hydrophobic) for all the compounds in separate
columns (Table 2). Molecular ﬁelds are the steric, electrostatic
and hydrophobic ﬁeld interaction energies which are used to
formulate a relationship between steric, electrostatic and
hydrophobic properties together with the biological activities
of compounds. QSAR analysis was performed after removal
of all the invariable columns, as they do not contribute to the
QSAR. This process forms the basis of a technique known as
feature selection or variable selection. Among several search
algorithms, stepwise (SW) forward variable selection method
(Darlington, 1990), genetic algorithms (Hasegawa et al.,
1999) and simulated annealing (Zheng and Tropsha, 2000)
based feature selection procedures are most popular for build-
ing QSAR models and can explain the situation more effec-
tively. In stepwise (SW) forward variable selection algorithm,
the search procedure begins with developing a trial model step
by step with a single independent variable and to each step;
independent variables are added one at a time, examining the
ﬁt of the model by using the partial least square cross-valida-
tion procedure. Thus, the model is repeatedly altered from
the previous one by adding or removing a predictor variable
in accordance with the ‘stepping criteria’ (in this case F= 4
for inclusion; F= 3.99 for exclusion for the forward–backward
selection method). The method continues until there is no more
signiﬁcant variable remaining outside the model. In the selected
equations, the cross-correlation limit was set at 0.5, the number
of variables at 10, and the term selection criteria at r2. An F va-
lue was speciﬁed to evaluate the signiﬁcance of a variable. The
variance cutoff was set at 0.0, and auto scaling in which the
number of random iterations was set at 100. Genetic algorithms
(GA) described by Holland is one of the most popular stochas-
tic optimization techniques that mimic natural evolution and
selection (Holland, 1992). It is a class of algorithms inspired
by the process of natural evolution in which species having a
high ﬁtness under some conditions can prevail and survive to
the next generation; the best species can be adapted by cross-
over and/or mutation in the search for better individuals. In
Table 2 Descriptors used in 3D QSAR model with values.
S_489 S_978 S_2083 E_869 E_563 E_1460 H_734 H_1146 H_2234 H_1501
0.00363 0.0005 0.00073 0.03421 0.03246 0.03214 0.314476 0.323801 0.328364 0.320293
0.00572 0.00054 0.00079 0.000244 0.00803 0.019417 0.320341 0.329602 0.332787 0.319581
0.00495 0.00148 0.00186 0.04938 0.06676 0.051716 0.359861 0.368125 0.368893 0.348776
0.00285 0.00112 0.00174 0.16175 0.14584 0.12204 0.3516 0.362019 0.365273 0.348536
0.01162 0.00067 0.00093 0.03493 0.0353 0.03122 0.352198 0.361437 0.364062 0.34836
0.00306 0.00057 0.00064 0.01606 0.01568 0.01335 0.375066 0.378534 0.373276 0.344861
0.00501 0.00097 0.00169 0.05544 0.03723 0.07225 0.409552 0.423047 0.430415 0.421899
0.00453 0.00184 0.00205 0.0675 0.0389 0.16446 0.521013 0.529608 0.520549 0.469372
0.00309 0.00096 0.00119 0.10191 0.10272 0.06209 0.394898 0.400664 0.401207 0.388045
0.00655 0.00064 0.00074 0.00758 0.00819 0.00773 0.446042 0.454914 0.454587 0.43178
0.0049 0.00055 0.00061 0.0183 0.01616 0.01959 0.448811 0.456638 0.452112 0.414127
0.00401 0.0086 0.00012 0.01415 0.011987 0.020502 0.307708 0.314317 0.318209 0.316989
0.00385 0.00067 0.00089 0.00451 0.00435 0.00665 0.380635 0.390737 0.392254 0.370626
0.00397 0.00065 0.0008 0.01105 0.008171 0.022738 0.325442 0.331315 0.329622 0.307326
0.00245 0.0006 0.00066 0.00836 0.010598 0.000398 0.45649 0.463325 0.458493 0.420888
0.00197 0.00063 0.00074 0.01626 0.01273 0.03976 0.338767 0.340727 0.335846 0.311409
0.00615 0.00011 0.00013 0.006119 0.00594 0.00975 0.282235 0.286915 0.288783 0.283757
0.0043 0.00011 0.00013 0.017937 0.01728 0.019227 0.291093 0.295252 0.296521 0.290198
0.00391 0.00071 0.00098 0.03268 0.02986 0.03815 0.388976 0.40335 0.40824 0.386363
0.00309 0.00066 0.00074 0.03298 0.02957 0.03685 0.44446 0.450943 0.446789 0.4125
0.00259 0.00078 0.00095 0.00387 0.00894 0.007113 0.256922 0.257847 0.254591 0.240547
0.00198 0.00014 0.00017 0.003732 0.001692 0.01426 0.261432 0.266297 0.268531 0.264626
0.00256 0.00046 0.00051 0.001184 0.006248 0.02174 0.375725 0.382196 0.379403 0.351842
0.0019 0.00011 0.00013 0.003845 0.002922 0.0087 0.306353 0.311113 0.31301 0.307896
0.0019 0.00053 0.0006 0.00231 0.001623 0.02107 0.387276 0.394377 0.390984 0.360006
0.00778 0.00012 0.00014 0.014391 0.015556 0.007849 0.296289 0.300587 0.302109 0.296481
0.00312 0.00012 0.00014 0.021417 0.022523 0.014895 0.285649 0.289944 0.291513 0.286142
0.00303 0.00059 0.00094 0.01923 0.018403 0.009038 0.348576 0.361242 0.367751 0.358246
0.00328 0.00012 0.00015 0.008827 0.008988 0.009415 0.257062 0.261561 0.263504 0.259359
0.00221 0.00012 0.00014 0.001659 0.002193 0.001141 0.26658 0.270885 0.272561 0.267743
0.00233 0.00063 0.00081 0.008575 0.010553 0.00855 0.36801 0.378004 0.37963 0.358342
0.00704 0.00044 0.00046 0.02876 0.02561 0.0332 0.338776 0.341767 0.33746 0.31262
0.00644 0.00045 0.0005 0.00915 0.00682 0.01619 0.325168 0.329264 0.325539 0.30107
0.00259 0.00069 0.00102 0.00103 0.00439 0.003437 0.340014 0.350204 0.354125 0.341527
0.00297 0.00062 0.00095 0.00871 0.01052 0.00958 0.363718 0.374667 0.379204 0.366883
0.00293 0.00086 0.00101 0.004252 0.005244 0.00773 0.401894 0.406965 0.402422 0.371464
0.00453 0.00055 0.00066 0.01852 0.0174 0.01926 0.401876 0.410119 0.408149 0.37869
0.0051 0.00057 0.00067 0.03215 0.0341 0.0082 0.390582 0.397559 0.395811 0.370226
0.01213 0.00076 0.00106 0.03483 0.03875 0.00871 0.324454 0.33312 0.335343 0.320279
0.02751 0.00062 0.00088 0.09752 0.07621 0.02596 0.315665 0.324037 0.327397 0.317119
Table 3 The unicolumn statistical analysis.
Column name Average Max Min StdDev Sum
Training set 7.1662 8.5200 4.5500 1.1068 207.8200
Test set 6.7209 8.5200 5.9200 0.8332 73.9300
172 M.C. Sharma et al.this method, a chromosome and its ﬁtness in the species repre-
sent a set of molecular descriptors and the cross-validated pre-
dictive accuracy of the derived QSAR model, respectively.
Here, a solution is typically encoded as a bit string consisting
of a series of the digits 1 and 0. The GA begins by generating
a set of random solutions (the population), which are analo-
gous to a set of chromosomes in a biological system. Simulated
annealing as variable selection method in order to select a sub-
set of descriptors (variables) from the descriptor pool, a vari-
able selection method like simulated annealing is required.
Simulated annealing mimics the physical process of annealing,
which involves heating a system to a high temperature and thengradually cooling it to a preset temperature (e.g., room temper-
ature). During this process, the system samples possible conﬁg-
urations are distributed according to the Boltzmann
distribution so that at equilibrium, low energy states are the
most populated (Kirkpatrick et al., 1983).
2.5. Model quality and validation
The developed QSAR models are evaluated using the follow-
ing statistical measures: N (the number of compounds in
regression); k (number of variables); DF (degree of freedom);
optimum component (number of optimum partial least square
components in the model); r2 (the squared correlation coefﬁ-
cient); F test (Fischer’s value) for statistical signiﬁcance; q2
(cross-validated correlation coefﬁcient); pred_r2 (r2 for exter-
nal test set); Z score (Z score calculated by the randomization
test); best_ran_q2 (highest q2 value in the randomization test);
best_ran_r2 (highest r2 value in the randomization test). The
regression coefﬁcient r2 is a relative measure of ﬁt by the
regression equation. It represents the part of the variation in
Table 4 Observed and predicted activities of statistically
signiﬁcant models obtained.
Comp. Observed activity Predicted activity
SW SA GA
1 6.39 6.76 6.26 6.00
2 5.92 5.75 6.16 5.52
3 5.92 6.28 5.71 6.31
4 6.07 5.80 5.84 5.60
5 6.31 6.13 6.16 5.91
6 5.76 5.93 5.58 5.40
7 6.08 5.81 5.87 5.70
8 6.26 6.01 6.08 5.83
9 5.97 5.65 5.70 5.54
10 5.24 5.53 5.03 4.85
11 6.33 6.19 6.64 5.90
12 6.74 6.58 6.89 6.33
13 5.74 5.35 5.44 5.30
14 4.53 4.30 4.35 4.19
15 6.09 5.77 6.18 5.72
16 7.58 7.29 7.31 7.10
17 6.79 6.54 6.83 6.26
18 6.40 6.15 6.22 6.13
19 6.79 6.42 6.48 6.28
20 7.06 6.79 7.31 6.58
21 7.61 7.38 7.53 7.24
22 7.58 7.33 7.34 7.13
23 7.48 7.16 7.24 7.11
24 7.46 7.24 7.27 7.90
25 7.09 6.76 6.80 6.62
26 7.67 7.36 7.83 7.19
27 8.0 8.08 7.81 7.53
28 8.09 7.63 7.73 7.70
29 8.52 8.15 8.65 8.14
30 8.39 8.67 8.22 8.08
31 8.52 8.16 8.59 8.24
32 8.52 8.25 8.69 8.88
33 7.88 7.59 8.05 7.40
34 8.30 8.09 8.17 7.91
35 8.39 8.54 8.28 8.59
36 8.52 8.20 8.69 8.16
37 8.30 8.01 8.12 7.89
38 7.95 7.72 7.79 7.43
39 6.61 6.21 6.34 6.26
40 6.80 6.44 6.51 6.47
Figure 2 Contribution plot of steric, electrostatic and hydro-
phobic ﬁeld interactions models.
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a QSAR model is considered to be predictive, if the following
conditions are satisﬁed: r2 > 0.6, q2 > 0.6 and pred_r2 > 0.5 (
Golbraikh and Tropsha, 2002). The F-test reﬂects the ratio of
the variance explained by the model and the variance due to
the error in the regression. High values of the F-test indicate
that the model is statistically signiﬁcant. The low standard er-
ror of pred_r2se, q2_se and r2_se shows absolute quality of ﬁt-
ness of the model. This is done to test the internal stability and
predictive ability of the QSAR models. Internal validation is
carried out (Cramer et al., 1988) using ‘leave-one-out’ (LOO)
method. The cross-validated coefﬁcient q2, is calculated using
the following equation
q2 ¼ 1
Pðyi  y^iÞ2
Pðyi  ymeanÞ2
where yi and y^i are the actual and predicted activity of the ith
molecule in the training set, respectively, and ymean is theaverage activity of all molecules in the training set. Both sum-
mations are over all molecules in the test set. The pred_r2 value
indicates the predictive power of the current model for the
external test set as follows: so, an external validation is also
carried out in the present study. The external predictive power
of the model is assessed by predicting pIC50 value of the 12 test
set molecules, which are not included in the QSAR model
development (Zheng and Tropsha, 2000). The predictive
ability of the selected model is also conﬁrmed by pred_r2:
Figure 3 Plot of observed versus predicted by best QSAR
models A, B and C.
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Pðyi  y^iÞ2
Pðyi  ymeanÞ2
To validate the generated QSAR models, the leave-one-out
method was used, indicated as the value of q2 (cross-validated
explained variance), which is a measure for the internal predic-
tive ability of the model. The cross-validation run returns the
optimum number of components for which it has the maxi-
mum cross-validated r2 (q2) values and the minimum standard
error of the prediction pred_r2se. The cross-validated r2 (q2)
value was calculated, where yi and y^i are, respectively, the ac-
tual and predicted activities of the ith molecule, and ymean is
the average activity of all the molecules in the training set.
Both summations are over all the molecules in the training
set. Because the calculation of the pair wise molecular similar-
ities, and hence the predictions, were based on the current trial
solution, the q2 obtained indicates the predictive power of the
current model. The signiﬁcance of the models hence obtainedis derived based on a calculated Z score (Zheng and Tropsha,
2000). A Zscore value is calculated by the following formula:
Zscore ¼ ðh lÞr
where h is the q2 value calculated for the actual dataset, l the
average q2, and r is its standard deviation calculated for vari-
ous iterations using models build by different random datasets.3. Results and discussion
The kNN-MFA technique was used to derive 3D-QSAR mod-
el for benzimidazoles derivatives. The in vitro inhibitory activ-
ity (IC50 values) in nM, were converted to pIC50 was used as
dependant variable. Relative alignment of all the energy mini-
mized molecules was then carried out by using a technique
namely atom and template based for better results and better
assessment between both. The kNN-MFA models were gener-
ated by using training set of 28 compounds and 3D-QSAR
models were validated using a test set of 12 compounds. The
steric (S), electrostatic (E) and hydrophobic (H) descriptors
specify the regions, where variation in the structural features
of different compounds in the training set leads to increase
or decrease in activities. The number accompanied by the
descriptors represents its position in the 3D MFA grid.
3.1. Model A: Stepwise (SW) variable selection
pIC50 = 0.2112 (S_978) + 0.2412 (H_2015) + 0.4036
(H_734)  0.0645 (E_869) + 0.1403 (E_2309) Ntraning = 28,
Ntest = 12, optimum components = 4, DF = 28,
r2 = 0.8061, q2 = 0.7961, F test = 59.432, r2_se = 0.6318,
q2_se = 0.6973, pred_r2 = 0.7395, pred_r2se = 0.5713, ZScore
Q^2 = 6.4321, Best Rand Q^2 = 0.6572
Model A the kNN-MFA model generated from template
based alignment showed q2 of 0.7961 with ﬁve descriptors
namely S_978, H_2015, H_734, E_869 and E_2309. A non-
cross-validated r2 of 0.8061, F value of 59.432 and number
nearest neighbors k of 4 were observed with this model. Steric,
electrostatic and hydrophobic ﬁeld energy of interactions be-
tween probe (CH3) and compounds at their corresponding spa-
tial grid points of 978, 2015, 734, 869 and 2309, which showed
the relative position and ranges of the corresponding impor-
tant electrostatic/steric and hydrophobic ﬁelds in the model,
provided guidelines for new molecule design. As far as S_978
steric ﬁeld is concerned, a negative range indicated that a neg-
ative steric potential was favorable for increased activity, and
hence a less bulky substituent group was preferred in that re-
gion. Freedom of an amide C–N bond compared to an acyclic
C–C bond is required for activity. The steric, electrostatic and
hydrophobic contributions were 22%, 48% and 30%, respec-
tively, and exhibited good external prediction with r2 pred of
0.7395 about 74%. Statistical signiﬁcance of the model indi-
cated by Z score value of 6.4321 and a of >0.0001. The above
model is validated by predicting the biological activities of the
test molecules, as indicated in Table 4 ability of kNN-MFA
model analysis. Positive range of electrostatic ﬁeld indicates
that less electronegative substituent would be favorable for
the activity as already the basic moiety taken in the study is
substituted with high electronegative groups like chlorine
and ﬂuorine so the other substituents employed should be less
electronegative. Positive contribution of H_734, to Hydrogen
3D QSAR kNN-MFA studies on 6-substituted benzimidazoles derivatives as Nonpeptide Angiotensin II 175group nearer to 4–7 indicates that positive hydrophobic ﬁeld is
favorable for increasing the activity. The presence of hydro-
phobic descriptors H_2015 (8%) with positive coefﬁcients are
also far from the R5 position of the benzimidazole ring which
indicates that bulky groups are unfavorable on this site and
presence of bulky groups decreases the Ang II activity of
substituted benzimidazoles compounds. The plot of contribu-
tions of steric, electrostatic and hydrophobic ﬁeld interactions
(Fig. 2) indicates relative regions of the local ﬁelds (steric, elec-
trostatic and hydrophobic) around the aligned molecules
(Kubinyi, 1997). Green, blue and yellow balls represent steric
electrostatic and hydrophobic ﬁeld effects, respectively. The
plot of observed versus predicted activities for the test com-
pounds is represented in Fig. 3(a).
3.2. Model B: Simulated annealing
pIC50 = 0.0026 (S_1018)  0.1250 (E_563)  0.5140
(S_2083) + 1.3239 (E_1460) + 0.0175 (E_160) + 0.3419
(H_2234) + 0.3444 (H_2491) + 0.5119 (H_1146) Ntraning =
28, Ntest = 12, optimum components = 4, DF = 30,
r2 = 0.8753, q2 = 0.8269, F test = 74.643, r2_se = 0.2143,
q2_se = 0.4365, pred_r2 = 0.7647, pred_r2se = 0.2165, ZScore
Q^2 = 8.4321, Best Rand Q^2 = 0.7635
Here, N represents number of observations, DF is the de-
grees of freedom, r is the square root of the multiple R-
squared for regression, q2 is the cross-validated r2, and F is
the F-statistic for the regression model. S_1018, E_563,
S_2083, E_1460, E_160, H_2234, H_2491 and H_1146 are
the steric, electrostatic and hydrophobic ﬁeld energy of inter-
actions between probe (CH3) and compounds at their corre-
sponding spatial grid points of 1018, 563, 2083, 1460, 160,
2234, and 1146. The external predictability of the above 3D-
QSAR model using the test set was determined by pred_r2,
which is 0.7647. So the above results indicate that 3D-QSAR
model for Ang II generates 82.6% and 76.4% internal and
external model prediction, respectively. S_1018 steric ﬁeld is
concerned, a negative range indicated that a negative steric
potential was favorable for increased activity, and hence a less
bulky substituent group was preferred in that region and
S_2083 with negative coefﬁcients are also far from the R posi-
tion of the benzimidazole ring which indicates that bulky
groups are unfavorable on this site and presence of bulky
groups decreases the Ang II activity. Positive value of descrip-
tors reveals that E_1460 electrostatic indicates that less elec-
tronegative substituent would be favorable for the activity
and E_160 positive coefﬁcients are also far from the R posi-
tion of the benzimidazole moiety which indicates that bulky
groups are unfavorable on this site and presence of bulky
groups decreases the Ang II activity. H_1146, H_2234,
H_2491, hydrophobic potential is favorable for increase in
activity in R4, R6 position and more bulky group is preferred
in that region. Hydrophobicity in the R6 position has a posi-
tive contribution on the activity, indicating that hydrophilic
groups in that position can enhance activity. The plot of con-
tributions of steric, electrostatic and hydrophobic ﬁeld inter-
actions (Fig. 2) indicates relative regions of the local ﬁelds
(steric, electrostatic and hydrophobic) around the aligned
molecules. The above model is validated by predicting the bio-
logical activities of the test molecules, as indicated in Table 4.
The plot of observed versus predicted activities for the test
compounds is represented in Fig. 3(b).3.3. Model C: Genetic algorithm
pIC50 = 0.0471 (S_1216) + 1.5547 (E_1460) + 0.3144
(H_1501)  0.0006 (S_489) Ntraning = 28, Ntest = 12, optimum
components = 4, DF = 26, r2 = 0.7853, q2 = 0.7428,
F test = 39.631, r2_se = 0.6532, q2_se = 0.8743, pred_r2 =
0.6952, pred_r2se = 0.4311, ZScore Q
^2 = 4.5432, Best Rand
Q^2 = 0.1547
The steric, electrostatic and hydrophobic contributions
were 35%, 38% and 27%, respectively, and exhibited good
external prediction with r2 pred of 0.6952, F value 39.631. Sta-
tistical signiﬁcance of the model indicated by Z score value of
4.5432 and a of >0.001. The randomization test suggests that
the developed model has a probability of less than 1% that the
model is generated by chance. The plot of contributions of ste-
ric, electrostatic and hydrophobic ﬁeld interactions model indi-
cates relative regions of the local ﬁelds (steric, electrostatic and
hydrophobic) around the aligned molecules. The above model
is validated by predicting the biological activities of the test
molecules, as indicated in Table 4. From 3D-QSAR model it
is observed that S_489 steric ﬁeld with negative coefﬁcient is
far from the moiety, indicating that bulky groups are unfavor-
able on this site and presence of bulky groups decreases the
Ang II activity. Positive E_1460 electrostatic groups are favor-
able on this site and presence of electronegative groups in-
crease the activity of compounds. Presence of electrostatic
ﬁeld in model with positive coefﬁcient (E_1460) suggests that
electropositive (electron-withdrawing) substituent may be
favorable on the position of 4 substituted benzimidazole tem-
plates. Presence of hydrophobic descriptors with positive coef-
ﬁcients simultaneously at R-positions of the, H_1501, suggests
the favourability of bulky groups in these regions for produc-
ing potent Ang II receptor activity. The plot of observed versus
predicted activities for the test compounds is represented in
Fig. 3(c).
4. Conclusion
The importance and utility of the new 3D QSAR method
discussed has been established by applying it to known sets
of molecules as described above. We report that 40, 3D
QSAR models were generated by kNN-MFA in conjunction
with simulated annealing (SA), genetic algorithms and step-
wise (SW) forward–backward selection methods. From these
models, two of them were having good q2 and pred-r2 val-
ues, one of which was selected having good internal and
external predictivity. To ascertain the true predictivity of
the model, applying leave-one-out method of cross-
validation using weighted k-nearest neighbor was performed
for all the analysis. A cross-validation analysis was also per-
formed by applying leave-one-out technique using weighted
k-nearest neighbor method. The contribution plot of steric,
electrostatic and hydrophobic ﬁeld interactions generated
by 3D-QSAR shows that electronegative groups at benz-
imidazole moiety are favorable for Ang II activity. Variable
selection is found to be very sensitive to the choice of muta-
tion probability and ﬁtness function, whereas simulated
annealing is quite robust with regard to the choice of cool-
ing schedule. This study shows how chemical features for a
set of compounds along with their activities ranging over
several orders of magnitudes can be used to generate QSAR
equation that can successfully predict the activity. Negative
176 M.C. Sharma et al.value of steric descriptors reveals that negative steric poten-
tial is favorable for increase in activity and less bulky substi-
tuent group was preferred in that region. Hydrophobicity in
the R6 position has a positive contribution on the activity,
indicating that hydrophilic groups in that position can in-
crease activity. The location, range of function values at
the ﬁeld points selected by model provide the clues for the
design of new molecules thus giving insight on structural
requirement for designing more potent analogues.Acknowledgement
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